97 related articles for article (PubMed ID: 16457056)
1. [Coverage and association with clinical variables of antipneumococcal vaccination of the population over 65 years old in Tarragona-Valls].
Vila Córcoles A; Ochoa Gondar O; Ansa Echeverría X; Bladé Creixenti J; Palacios Llamazares L; Fuentes Bellido CM
Rev Esp Salud Publica; 2005; 79(6):645-54. PubMed ID: 16457056
[TBL] [Abstract][Full Text] [Related]
2. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up.
Vila-Córcoles A; Ochoa-Gondar O; Ester F; Sarrá N; Ansa X; Saún N;
BMC Public Health; 2006 Sep; 6():231. PubMed ID: 16981982
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
[TBL] [Abstract][Full Text] [Related]
4. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
[TBL] [Abstract][Full Text] [Related]
5. Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study.
Jackson LA; Baxter R; Naleway AL; Belongia EA; Baggs J
BMC Infect Dis; 2009 Mar; 9():37. PubMed ID: 19321001
[TBL] [Abstract][Full Text] [Related]
6. [Evolution of the antipneumococcal vaccination coverage among children in the region of Tarragona, Spain, 2002-2011].
Vila Córcoles A; Ochoa Gondar O; Gutiérrez Pérez A; de Diego Cabanes C; Vila Rovira A; González Lamban B
Rev Esp Salud Publica; 2012 Dec; 86(6):637-43. PubMed ID: 23325138
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with pneumococcal vaccination among an urban elderly population in China.
Liu S; Xu E; Liu Y; Xu Y; Wang J; Du J; Zhang X; Che X; Gu W
Hum Vaccin Immunother; 2014; 10(10):2994-9. PubMed ID: 25483646
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects.
Vila-Córcoles A; Ochoa-Gondar O; Llor C; Hospital I; Rodríguez T; Gómez A
Eur Respir J; 2005 Dec; 26(6):1086-91. PubMed ID: 16319340
[TBL] [Abstract][Full Text] [Related]
9. Impact of pneumococcal polysaccharide vaccine on incidence and mortality after pneumonia in adults aged ≥60 years-a population-based retrospective cohort study.
Kolditz M; Schmitt J; Pletz MW; Tesch F
Clin Microbiol Infect; 2018 May; 24(5):500-504. PubMed ID: 28830805
[TBL] [Abstract][Full Text] [Related]
10. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain.
Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P
J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.
Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A;
Hum Vaccin Immunother; 2012 May; 8(5):639-44. PubMed ID: 22634442
[TBL] [Abstract][Full Text] [Related]
12. [Pneumococcal vaccination coverage in at-risk children in Catalonia].
González R; Armadans L; Martínez X; Moraga F; Campins M
Enferm Infecc Microbiol Clin; 2015 Nov; 33(9):597-602. PubMed ID: 25703208
[TBL] [Abstract][Full Text] [Related]
13. Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies.
Kyaw MH; Wayne B; Chalmers J; Jones IG; Campbell H
Epidemiol Infect; 2002 Jun; 128(3):445-55. PubMed ID: 12113489
[TBL] [Abstract][Full Text] [Related]
14. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention?
Arencibia Jiménez M; Navarro Gracia JF; Delgado de Los Reyes JA; Pérez Torregrosa G; López Parra D; López García P
Arch Bronconeumol; 2014 Mar; 50(3):93-8. PubMed ID: 24315186
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of increased influenza and pneumococcal vaccination coverage in long-term care facilities: the CMS-CDC standing orders program Project.
Bardenheier BH; Shefer A; McKibben L; Roberts H; Rhew D; Bratzler D
J Am Med Dir Assoc; 2005; 6(5):291-9. PubMed ID: 16165069
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia.
Vila-Corcoles A; Ochoa-Gondar O; Hospital I; de Diego C; Satué E; Bladé J; Ansa X; Guzmán JA; Salsench E; Ramos F
Hum Vaccin Immunother; 2016 Nov; 12(11):2953-2958. PubMed ID: 27454779
[TBL] [Abstract][Full Text] [Related]
18. Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study.
Vila-Corcoles A; Ochoa-Gondar O; de Diego C; Satue E; Aragón M; Vila-Rovira A; Gomez-Bertomeu F; Magarolas R; Figuerola-Massana E; Raga X; Perez MO; Ballester F
BMC Infect Dis; 2018 Apr; 18(1):196. PubMed ID: 29699550
[TBL] [Abstract][Full Text] [Related]
19. Coverage of and factors associated with pneumococcal vaccination in chronic obstructive pulmonary disease.
Carreño-Ibáñez LV; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; González Del Yerro C; Iniesta-Fornies D; Gascón-Sancho MJ; Jiménez-García R
Int J Tuberc Lung Dis; 2015 Jun; 19(6):735-41. PubMed ID: 25946369
[TBL] [Abstract][Full Text] [Related]
20. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
Tsaban G; Ben-Shimol S
Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
